BLOOMBERG - By Jef Feeley and Laurence Viele Davidson Roche Holding AG’s Genentech Inc. is facing the first trial of patients’ claims that its withdrawn Raptiva psoriasis drug spawned fatal infections in some users. Officials of Genentech, a unit of Basel, Switzerland-based drugmaker Roche, are readying for a Jan. 30 jury trial in state court in
Read More::
3 Comments » 
on Illegal Marketing of Anti-Seizure Drug Depakote Costs Abbott Laboratories 1.6 BillionReg-Abbott labs off-label promotion of Depakote. I took Depakote for 6 years was ineffective for my condition PTSD,the doctor kept
on EMA Probes Novartis MS Pill Over DeathsHi Crissy - This is attorney Jami Haggerty. Our Facebook link is http://www.facebook.com/pages/Ennis-Ennis-PA/107176862655651. Visit our page and become a fan.
on Florida’s Rexall recalls vitamins over shellfish fearsIt took me time to learn all the comments, but I honestly loved the blog. It proved to be very
on Roche Faces First Trial of Claims Over Raptiva InfectionsVivian this is David Ennis and thank your for your reply. We have our own facebook, twitter and youtube page. on J&J Pays $158M To Settle Risperdal Lawsuit In TexasRisperal reproached. Same saga here as Eli Lilly Zyprexa. Johnson and Johnson is a trusted brand we associate with babies.
on Roche Faces First Trial of Claims Over Raptiva Infectionsi love your blog, i have it in my rss reader and always like new things coming up from it.
